IceCure Medical Ltd (ICCM)
USD 1.14
(-7.67%)
USD 1.14
(-7.67%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.3 Million USD | -10.03% |
| 2022 | 1.44 Million USD | -34.17% |
| 2021 | 2.19 Million USD | -17.43% |
| 2020 | 2.65 Million ILS | 361.19% |
| 2019 | 576.41 Thousand ILS | 28.45% |
| 2018 | 448.72 Thousand ILS | 156.51% |
| 2017 | 174.93 Thousand ILS | -21.02% |
| 2016 | 221.49 Thousand ILS | -19.94% |
| 2015 | 276.66 Thousand ILS | -26.51% |
| 2014 | 376.48 Thousand ILS | 478.93% |
| 2013 | -99.35 Thousand ILS | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 266.59 Thousand USD | -55.49% |
| 2024 Q2 | 522.57 Thousand USD | 98.8% |
| 2023 Q3 | -23 Thousand USD | -105.3% |
| 2023 FY | 1.3 Million USD | -10.03% |
| 2023 Q1 | 320 Thousand USD | -30.59% |
| 2023 Q2 | 434 Thousand USD | 35.63% |
| 2023 Q4 | 598.96 Thousand USD | 2704.17% |
| 2022 Q2 | 384 Thousand USD | -11.52% |
| 2022 FY | 1.44 Million USD | -34.17% |
| 2022 Q4 | 461 Thousand USD | 177.71% |
| 2022 Q1 | 434 Thousand USD | -32.5% |
| 2022 Q3 | 166 Thousand USD | -56.77% |
| 2021 Q4 | 643 Thousand USD | 79.11% |
| 2021 Q2 | 254 Thousand USD | -72.95% |
| 2021 Q1 | 939 Thousand USD | 10.99% |
| 2021 FY | 2.19 Million USD | -17.43% |
| 2021 Q3 | 359 Thousand USD | 41.34% |
| 2020 FY | 2.65 Million ILS | 361.19% |
| 2020 Q4 | 846 Thousand USD | 91.84% |
| 2020 Q2 | 578.5 Thousand USD | 0.0% |
| 2020 Q1 | 578.5 Thousand USD | 163.9% |
| 2020 Q3 | 441 Thousand USD | -23.77% |
| 2019 Q3 | 217.76 Thousand USD | 222.49% |
| 2019 Q4 | 219.21 Thousand USD | 0.66% |
| 2019 FY | 576.41 Thousand ILS | 28.45% |
| 2019 Q2 | 67.52 Thousand USD | 1.79% |
| 2019 Q1 | 66.34 Thousand USD | -45.35% |
| 2018 Q1 | 107.25 Thousand USD | 591.09% |
| 2018 FY | 448.72 Thousand ILS | 156.51% |
| 2018 Q4 | 121.4 Thousand USD | -9.32% |
| 2018 Q3 | 133.88 Thousand USD | 30.79% |
| 2018 Q2 | 102.37 Thousand USD | -4.56% |
| 2017 Q3 | 11.59 Thousand USD | -87.42% |
| 2017 FY | 174.93 Thousand ILS | -21.02% |
| 2017 Q4 | -21.84 Thousand USD | -288.32% |
| 2017 Q1 | 88.76 Thousand USD | 438.24% |
| 2017 Q2 | 92.16 Thousand USD | 3.83% |
| 2016 Q4 | -26.24 Thousand USD | -128.88% |
| 2016 Q1 | 90.97 Thousand USD | 13.09% |
| 2016 Q2 | 70.1 Thousand USD | -22.93% |
| 2016 Q3 | 90.88 Thousand USD | 29.63% |
| 2016 FY | 221.49 Thousand ILS | -19.94% |
| 2015 Q3 | 72.86 Thousand USD | 72.89% |
| 2015 Q4 | 80.44 Thousand USD | 10.39% |
| 2015 Q2 | 42.14 Thousand USD | -47.95% |
| 2015 Q1 | 80.97 Thousand USD | -61.24% |
| 2015 FY | 276.66 Thousand ILS | -26.51% |
| 2014 Q3 | 106.96 Thousand USD | -37.08% |
| 2014 FY | 376.48 Thousand ILS | 478.93% |
| 2014 Q1 | -93.12 Thousand USD | -134.0% |
| 2014 Q2 | 169.99 Thousand USD | 282.55% |
| 2014 Q4 | 208.91 Thousand USD | 95.31% |
| 2013 Q4 | -39.79 Thousand USD | -161.83% |
| 2013 Q1 | -44.42 Thousand USD | 36.93% |
| 2013 FY | -99.35 Thousand ILS | 0.0% |
| 2013 Q2 | -75.08 Thousand USD | -69.0% |
| 2013 Q3 | 64.37 Thousand USD | 185.73% |
| 2012 Q4 | -70.43 Thousand USD | 6.41% |
| 2012 Q3 | -75.26 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | 49.02% |
| BrainsWay Ltd. | 23.09 Million USD | 94.37% |
| Cerus Corporation | 86.4 Million USD | 98.495% |
| Envoy Medical, Inc. | -473 Thousand USD | 374.841% |
| electroCore, Inc. | 13.22 Million USD | 90.171% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -2031.148% |
| Inogen, Inc. | 126.69 Million USD | 98.974% |
| OrthoPediatrics Corp. | 111.25 Million USD | 98.831% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 121.488% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 2846.324% |
| MaxCyte, Inc. | 36.54 Million USD | 96.443% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -184.765% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1428.333% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.733% |
| PAVmed Inc | -3.96 Million USD | 132.762% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 123.701% |
| RxSight, Inc. | 53.76 Million USD | 97.582% |
| Sight Sciences, Inc. | 69.17 Million USD | 98.121% |
| SI-BONE, Inc. | 109.42 Million USD | 98.812% |
| TELA Bio, Inc. | 40.11 Million USD | 96.759% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 99.144% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 84.282% |
| Acutus Medical, Inc. | -3.13 Million USD | 141.441% |
| Talis Biomedical Corporation | 371 Thousand USD | -250.404% |
| Spectral AI, Inc. | 7.88 Million USD | 83.503% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 119.721% |
| CVRx, Inc. | 33.03 Million USD | 96.065% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -75.788% |
| Bioventus Inc. | 328.19 Million USD | 99.604% |
| Venus Concept Inc. | 52.16 Million USD | 97.508% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 91.827% |
| LivaNova PLC | 771.25 Million USD | 99.831% |
| 908 Devices Inc. | 25.32 Million USD | 94.866% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.581% |
| Nemaura Medical Inc. | -1.47 Million USD | 188.052% |
| NeuroPace, Inc. | 48.12 Million USD | 97.299% |
| LENSAR, Inc. | 21.1 Million USD | 93.841% |
| Apyx Medical Corporation | 14.12 Million USD | 90.795% |
| Cutera, Inc. | 41.49 Million USD | 96.867% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 92.958% |
| BioSig Technologies, Inc. | 18 Thousand USD | -7122.222% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 98.739% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 90.451% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.854% |
| Axonics, Inc. | 274.55 Million USD | 99.527% |
| Outset Medical, Inc. | 29 Million USD | 95.517% |
| IRIDEX Corporation | 21.8 Million USD | 94.039% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 98.17% |
| IRadimed Corporation | 50.15 Million USD | 97.408% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -352.962% |
| INVO Bioscience, Inc. | 1.08 Million USD | -19.69% |
| Telesis Bio, Inc. | 16.95 Million USD | 92.33% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 98.847% |
| Varex Imaging Corporation | 256.9 Million USD | 99.494% |
| Quipt Home Medical Corp. | 163.84 Million USD | 99.207% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 420.197% |
| Pulmonx Corporation | 50.75 Million USD | 97.439% |
| Dynatronics Corporation | 7.63 Million USD | 82.973% |
| Modular Medical, Inc. | -768 Thousand USD | 269.271% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 76.568% |
| Semler Scientific, Inc. | 61.2 Million USD | 97.876% |
| InMode Ltd. | 411.34 Million USD | 99.684% |
| Bruker Corporation | 1.51 Billion USD | 99.914% |
| Cytosorbents Corporation | 22.39 Million USD | 94.194% |
| DexCom, Inc. | 2.28 Billion USD | 99.943% |
| Align Technology, Inc. | 2.71 Billion USD | 99.952% |
| Viveve Medical, Inc. | 620 Thousand USD | -109.677% |
| ZimVie Inc. | 290.38 Million USD | 99.552% |
| Movano Inc. | -158 Thousand USD | 922.785% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 98.812% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -1428.333% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.646% |
| Profound Medical Corp. | 4.51 Million USD | 71.201% |
| Insulet Corporation | 1.15 Billion USD | 99.888% |
| enVVeno Medical Corporation | -546 Thousand USD | 338.095% |
| Surmodics, Inc. | 93.05 Million USD | 98.603% |
| iCAD, Inc. | 14.53 Million USD | 91.057% |
| Nuwellis, Inc. | 4.98 Million USD | 73.911% |
| Biotricity, Inc. | 8.35 Million USD | 84.443% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.608% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 462.06% |
| InspireMD, Inc. | 1.8 Million USD | 28.058% |
| PAVmed Inc. | -3.96 Million USD | 132.762% |
| BIOLASE, Inc. | 16.72 Million USD | 92.227% |
| Beyond Air, Inc. | -1.3 Million USD | 199.464% |
| FONAR Corporation | 45.14 Million USD | 97.12% |
| AxoGen, Inc. | 127.87 Million USD | 98.983% |
| Vivani Medical, Inc. | -357 Thousand USD | 464.146% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 99.334% |
| Inari Medical, Inc. | 434.56 Million USD | 99.701% |
| UFP Technologies, Inc. | 112.22 Million USD | 98.842% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -10284.216% |
| Tenon Medical, Inc. | 1.24 Million USD | -4.754% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 1704.938% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 50.516% |
| AdaptHealth Corp. | 479.56 Million USD | 99.729% |
| Sintx Technologies, Inc. | 1.84 Million USD | 29.463% |
| NanoVibronix, Inc. | 1.53 Million USD | 15.42% |
| Quanterix Corporation | 70.64 Million USD | 98.16% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 420.197% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 90.754% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 97.537% |
| TransMedics Group, Inc. | 154.09 Million USD | 99.156% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 70.806% |
| NeuroMetrix, Inc. | 3.94 Million USD | 67.067% |
| Hyperfine, Inc. | 4.75 Million USD | 72.672% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 98.785% |
| Biomerica, Inc. | 611 Thousand USD | -112.766% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 96.882% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 266.463% |
| Silk Road Medical, Inc | 127.08 Million USD | 98.977% |